Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,143,081
+$100,911,462 QoQ
Shares Held
188,515
+8976.3% QoQ
Ownership
0.440%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#51
of 870 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $124,492,646 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (82.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
188,515 | $102,143,081 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
345,899 | $11,719,058 | |
| 3 | ALKS |
Alkermes plc.
|
120,243 | $6,300,733 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
24,037 | $4,051,195 | |
| 5 | VTRS |
Viatris Inc
|
15,778 | $250,554 | |
| 6 | ZTS |
Zoetis Inc.
|
390 | $28,025 |
All Filings in UTHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,143,081 | 188,515 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,231,619 | 2,077 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,897,838 | 3,895 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,106,714 | 2,640 | Shares | Defined | 2025-11-14 | |
| 2022-12-31 | $58,955 | 212 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $63,023 | 301 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $45,478 | 193 | Shares | Defined | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||